Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation (2020) Vol. 39, Iss. 12, pp. 1435-1444
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Heart Journal (2022) Vol. 43, Iss. 38, pp. 3618-3731
Open Access | Times Cited: 2102
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200879-2200879
Open Access | Times Cited: 1177
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Marius M. Hoeper, Christine Pausch, Karen M. Olsson, et al.
European Respiratory Journal (2021) Vol. 60, Iss. 1, pp. 2102311-2102311
Open Access | Times Cited: 205
The physiological basis of pulmonary arterial hypertension
Robert Naeije, Manuel J. Richter, Lewis J. Rubin
European Respiratory Journal (2021) Vol. 59, Iss. 6, pp. 2102334-2102334
Open Access | Times Cited: 120
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Marius M. Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 10, pp. 937-948
Open Access | Times Cited: 109
Treatment of pulmonary arterial hypertension: recent progress and a look to the future
Marc Humbert, Olivier Sitbon, Christophe Guignabert, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 9, pp. 804-819
Closed Access | Times Cited: 56
Treatment algorithm for pulmonary arterial hypertension
Kelly Chin, Seán Gaine, Christian Gerges, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401325-2401325
Open Access | Times Cited: 24
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 6, pp. 2102024-2102024
Open Access | Times Cited: 82
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Karen M. Olsson, Marius M. Hoeper, Christine Pausch, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 2, pp. 2101483-2101483
Open Access | Times Cited: 80
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement
Laura Price, Guillermo Martinez, Aimée Brame, et al.
British Journal of Anaesthesia (2021) Vol. 126, Iss. 4, pp. 774-790
Closed Access | Times Cited: 79
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
Stephan Rosenkranz, Christine Pausch, Gerry Coghlan, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 42, Iss. 1, pp. 102-114
Open Access | Times Cited: 47
The evolving landscape of pulmonary arterial hypertension clinical trials
Jason Weatherald, Athénaïs Boucly, Anthony Peters, et al.
The Lancet (2022) Vol. 400, Iss. 10366, pp. 1884-1898
Open Access | Times Cited: 47
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment
Charles Fauvel, O Raitiere, Athénaïs Boucly, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 12, pp. 1761-1772
Closed Access | Times Cited: 41
Pulmonary arterial hypertension
Athénaïs Boucly, Christian Gerges, Laurent Savale, et al.
La Presse Médicale (2023) Vol. 52, Iss. 3, pp. 104168-104168
Closed Access | Times Cited: 28
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary Hypertension
Lucilla Piccari, Brian Allwood, Katerina Antoniou, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 24
Pulmonary hypertension associated with lung diseases
Oksana A. Shlobin, Yochai Adir, Joan Albert Barberá, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401200-2401200
Open Access | Times Cited: 15
Outcomes and risk assessment in pulmonary veno-occlusive disease
Athénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
ERJ Open Research (2024) Vol. 10, Iss. 1, pp. 00612-2023
Open Access | Times Cited: 9
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT
Krit Dwivedi, Michael Sharkey, Liam Delaney, et al.
Radiology (2024) Vol. 310, Iss. 2
Closed Access | Times Cited: 9
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
Stephan Rosenkranz, Richard N. Channick, Kelly Chin, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 1, pp. 205-214
Open Access | Times Cited: 41
Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
James Anderson, Edmund Lau
JACC Asia (2022) Vol. 2, Iss. 5, pp. 538-546
Open Access | Times Cited: 33
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH
Christina A. Eichstaedt, Catharina Belge, Wendy K. Chung, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 2, pp. 2201471-2201471
Open Access | Times Cited: 30
New trends in pulmonary hypertension
Sarah Cullivan, Seán Gaine, Olivier Sitbon
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220211-220211
Open Access | Times Cited: 17
Phenotypes in pulmonary hypertension
Jason Weatherald, Anna R. Hemnes, Bradley A. Maron, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 3, pp. 2301633-2301633
Closed Access | Times Cited: 7
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension
Shalaleh Zendehdel Baher, Shadi Yaqoubi, Kofi Asare‐Addo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 895-895
Open Access | Times Cited: 23
Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension
Eileen M. Harder, Miguel Divo, George R. Washko, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 316-324
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top